Research
Open Access
Cost–utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer
Miriam Kimpton, Srishti Kumar, Philip S. Wells, Doug Coyle, Marc Carrier and Kednapa Thavorn
CMAJ October 12, 2021 193 (40) E1551-E1560; DOI: https://doi.org/10.1503/cmaj.210523
Miriam Kimpton
Department of Medicine and the Ottawa Hospital Research Institute (Kimpton, Kumar, Wells, Carrier, Thavorn), and School of Epidemiology and Public Health (Coyle, Thavorn), University of Ottawa, Ottawa, Ont.
MDSrishti Kumar
Department of Medicine and the Ottawa Hospital Research Institute (Kimpton, Kumar, Wells, Carrier, Thavorn), and School of Epidemiology and Public Health (Coyle, Thavorn), University of Ottawa, Ottawa, Ont.
BSc MAPhilip S. Wells
Department of Medicine and the Ottawa Hospital Research Institute (Kimpton, Kumar, Wells, Carrier, Thavorn), and School of Epidemiology and Public Health (Coyle, Thavorn), University of Ottawa, Ottawa, Ont.
MD MScDoug Coyle
Department of Medicine and the Ottawa Hospital Research Institute (Kimpton, Kumar, Wells, Carrier, Thavorn), and School of Epidemiology and Public Health (Coyle, Thavorn), University of Ottawa, Ottawa, Ont.
MSc PhDMarc Carrier
Department of Medicine and the Ottawa Hospital Research Institute (Kimpton, Kumar, Wells, Carrier, Thavorn), and School of Epidemiology and Public Health (Coyle, Thavorn), University of Ottawa, Ottawa, Ont.
MD MScKednapa Thavorn
Department of Medicine and the Ottawa Hospital Research Institute (Kimpton, Kumar, Wells, Carrier, Thavorn), and School of Epidemiology and Public Health (Coyle, Thavorn), University of Ottawa, Ottawa, Ont.
MPharm PhDData supplements
Online Appendices
Related Articles
- Bayoumi, A., & Laupacis, A. (2021). Outdated criteria for drug plan reimbursement obstruct evidence-based care. CMAJ, 193(40), E1573-E1574. Accessed April 19, 2024. https://doi.org/10.1503/cmaj.211617.
In this issue
Article tools
Respond to this article
Cost–utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer
Miriam Kimpton, Srishti Kumar, Philip S. Wells, Doug Coyle, Marc Carrier, Kednapa Thavorn
CMAJ Oct 2021, 193 (40) E1551-E1560; DOI: 10.1503/cmaj.210523